RESTORE TRIAL: A Phase 2 Study Evaluating the Efficacy and Safety of Pemvidutide in the Treatment of Alcohol-Associated Liver Disease (ALD)
for Alcohol Liver Disease
42 locations incl. Peoria
Sponsor: Altimmune, Inc.
Sex: All·Age: 18 - 75
Code: NCT07009860·Phase 2·Recruiting·Listed Jun 2025